Viewing Study NCT04447092


Ignite Creation Date: 2025-12-24 @ 3:16 PM
Ignite Modification Date: 2025-12-30 @ 4:40 PM
Study NCT ID: NCT04447092
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-19
First Post: 2020-06-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab Plus Chemotherapy in 1st Line Treatment of Pancreatic Cancer
Sponsor: Seoul National University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module